Leptin deficiency and mutations in the leptin receptor are recognized rare causes of monogenic early onset, severe obesity (86, 87), and recombinant leptin replacement therapy produces significant clinical benefit in these patients (88). This evidence concerns the gene LEP and hyperinsulinemic hypoglycemia, familial, 4.